CAS RN 152459-95-5
Imatinib, TRC
CAS: 152459-95-5 Summenformel: C29 H31 N7 O Molekulargewicht (g/mol): 493.6 Synonym: Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide,4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide,CGP 57148,Genfatinib,Imatinib IUPAC-Name: 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-Pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamid SMILES: CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1
Imatinib, Mikromol™
Entdecken Mikromol - Ihre zuverlässige Quelle für hochwertige pharmazeutische Referenzstandards. Unterstützung genauer, konformer Analysen mit ISO Materialien, die gemäß ISO 17034 akkreditiert sind und für Vertrauen in jedes Ergebnis sorgen.
Imatinib, MedChemExpress
MedChemExpress Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV.